An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease
Tafere Mulaw Belete Department of Pharmacology, College of Medicine and Health Sciences, University of Gondar, Gondar, EthiopiaCorrespondence: Tafere Mulaw Belete Tel +251 918045943Email mutafere@yahoo.comAbstract: Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has a great potential...
Enregistré dans:
Auteur principal: | Mulaw Belete T |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8d554f858af04c90b29dc8788b26d7cb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
par: Rouamba T, et autres
Publié: (2021) -
Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review
par: Saghir SAM, et autres
Publié: (2021) -
Glycopeptides as Potential Interventions for COVID-19
par: Demsie DG, et autres
Publié: (2020) -
Hypercytokinemia and Pathogen–Host Interaction in COVID-19
par: Badawi A
Publié: (2020) -
N-Acetylcysteine to Combat COVID-19: An Evidence Review
par: Shi Z, et autres
Publié: (2020)